Trademark Search in Canada

REATA PHARMACEUTICALS

View On IC.GC.CA

REGISTERED

on 4 Oct 2024

Last Applicant/ Owned by

REATA PHARMACEUTICALS INC.

5320 Legacy DrivePlano TX 75024

Serial Number

2156243 filed on 10^th Nov 2021

Registration Number

TMA1261099 registered on 4^th Oct 2024

Registration expiry Date

10^th Nov 2031

Correspondent Address

NORTON ROSE FULBRIGHT CANADA LLP/S.E.N.C.R.L.,S.R.L.

3700 CANTERRA TOWER400 - THIRD AVENUE S.W.CALGARY

ALBERTA

T2P4H2

REATA PHARMACEUTICALS

Trademark usage description

pharmaceutical preparations for the prevention and treatment of neurological disorders and degenerative nerve disorders, namely, friedreich's ataxia, Read More

Vienna Information

25 . 7 . 1

Surfaces or backgrounds covered with repeated geometrical figures or designsSurfaces ou fonds couverts de figures ou de motifs géométriques répétés

25 . 7 . 6

Surfaces or backgrounds covered with circles or ellipsesSurfaces ou fonds couverts de cercles ou d'ellipses

25 . 7 . 7

Surfaces or backgrounds covered with dotsSurfaces ou fonds couverts de points

26 . 4 . 1

SquaresCarrés

26 . 4 . 5

One quadrilateralUn quadrilatère

26 . 4 . 10

Quadrilaterals containing one or more circles, ellipses or polygonsQuadrilatères contenant un ou plusieurs cercles, ellipses ou polygones

Classification Information

Class [005]
Pharmaceutical preparations for the prevention and treatment of neurological disorders and degenerative nerve disorders, namely, Friedreich's Ataxia, diabetic peripheral neuropathy, Alzheimer's disease, Parkinson's disease, Huntington's disease, multiple sclerosis, demyelinating nerve disease, ALS and epilepsy; pharmaceutical preparations for the prevention and treatment of disorders of the central nervous system, namely, brain, movement, ocular motility and spinal cord diseases; pharmaceutical preparations for the prevention and treatment of disorders of the cardiovascular system; pharmaceutical preparations for the prevention and treatment of metabolic disorders, namely, diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, bulimia nervosa, anorexia, obesity, hypothyroidism and mitochondrial disease; pharmaceutical preparations for the prevention and treatment of disorders of the respiratory system; pharmaceutical preparations for the prevention and treatment of disorders of the musculo-skeletal system; pharmaceutical preparations for use in oncology, ophthalmology, and the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the immune system, namely, herpes, hepatitis, HIV infections, Acquired Immune Deficiency Syndrome (AIDS), and autoimmune diseases; pharmaceutical preparations for the treatment and prevention of acute or chronic kidney disease; pharmaceutical preparations for the prevention and treatment of skin diseases and disorders, namely, fibrotic skin disease and inflammatory skin disorders

Classification kind code

Mark Details

Serial Number

2156243

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 48 on 10^th Jun 2024	Agent Changed
Submitted for opposition 22 on 5^th Apr 2023	Search Recorded
Submitted for opposition 20 on 5^th Apr 2023	Examiner's First Report
Submitted for opposition 223 on 5^th Apr 2023	Total Provisional Refusal
Submitted for opposition 256 on 24^th Oct 2022	Notification of Possible Opposition Sent
Submitted for opposition 257 on 23^rd Dec 2021	Designation Notification - Madrid Protocol
Submitted for opposition 31 on 22^nd Dec 2021	Formalized
Submitted for opposition 1 on 22^nd Dec 2021	Created
Submitted for opposition 228 on 10^th Nov 2021	International Registration
Submitted for opposition 30 on 10^th Nov 2021	Filed